What is Perosphere?
Perosphere operates within the specialty pharmaceutical industry, leveraging internationally recognized drug delivery expertise. The company's strategic focus involves identifying market opportunities where existing drugs can be enhanced through advanced delivery technologies to create new medical uses or improve safety, efficacy, and ease of administration. Additionally, Perosphere selectively develops novel chemical entities and therapeutics designed as 'rescue' drugs. Their lead candidate, PER977, is a clinical-stage anticoagulant reversal agent targeting direct factor Xa- and IIa-inhibitors, representing a critical advancement in managing bleeding complications associated with anticoagulant therapies.
How much funding has Perosphere raised?
Perosphere has raised a total of $8.9M across 4 funding rounds:
Series A
$1M
Debt
$1.5M
Series B
$6.2M
Debt
$150K
Series A (2011): $1M, investors not publicly disclosed
Debt (2014): $1.5M led by Connecticut Innovations
Series B (2015): $6.2M, investors not publicly disclosed
Debt (2020): $150K featuring PPP
Key Investors in Perosphere
Connecticut Innovations
Connecticut Innovations (ctinnovations.com) is Connecticuts strategic venture capital arm and quasipublic investment agency, providing equity and debt financing, strategic guidance, and connections to help innovative, growing companies in the state scale, with dedicated funds for sectors like AI/quantum, climate tech, and biosciences.
What's next for Perosphere?
With the recent infusion of major strategic capital, Perosphere is poised to accelerate the development and commercialization of its promising drug candidates, particularly PER977. The company's established expertise in drug delivery, combined with its focus on addressing critical unmet medical needs, positions it for significant growth. Future endeavors will likely involve advancing PER977 through late-stage clinical trials, seeking regulatory approvals, and potentially exploring strategic partnerships to maximize market penetration. The sustained investment signals a strong belief in Perosphere's ability to navigate the complex pharmaceutical landscape and deliver impactful therapeutic solutions.
See full Perosphere company page
